Business Combinations (Tables)

12 Months Ended

Dec. 31, 2017

Schedule of Recognized Identified Assets Acquired and Liabilities Assumed

The following table represents the allocation of the purchase price to the assets acquired and the liabilities assumed by the Company during each acquisition, respectively, reconciled to the purchase price transferred included in the Company's Consolidated Balance Sheet:



	Aesynt		Ateb		Total
	(In thousands)
Cash	$	8,164	$	902	$	9,066
Accounts receivable	43,312		7,761		51,073
Inventory	19,021		225		19,246
Other current assets	3,787		1,239		5,026
Total current assets	74,284		10,127		84,411
Property and equipment	10,389		2,447		12,836
Intangible assets	123,700		12,500		136,200
Goodwill	163,599		24,232		187,831
Other non-current assets	968		334		1,302
Total assets	372,940		49,640		422,580
Current liabilities	26,753		4,895		31,648
Deferred revenue, net	25,512		2,776		28,288
Non-current deferred tax liabilities	38,622		—		38,622
Other non-current liabilities	2,431		367		2,798
Total liabilities	93,318		8,038		101,356
Total purchase price	279,622		41,602		321,224
Total purchase price, net of cash received	$	271,458	$	40,700	$	312,158

Intangible Assets Acquired

The identifiable intangible assets acquired and their estimated useful lives for amortization are as follows:



	Aesynt			Ateb
	Fair value		Weighted average useful life	Fair value		Weighted average useful life
	(In thousands)		(In years)	(In thousands)		(In years)
Customer relationships	$	58,200	14-16	$	8,900	12
Developed technology	38,800		8	3,400		5
Backlog	20,200		1-3	—		-
In-process research and development ("IPR&D") ⁽¹⁾	3,900		-	—		-
Non-compete	1,800		3	100		1
Trade names	800		1	100		1
Total purchased intangible assets	$	123,700		$	12,500

⁽¹⁾The amortization of the in-process R&D assets begins when the in-process R&D projects are complete.

Business Acquisition, Pro Forma Information

The pro forma adjustments include the impact of fair value adjustment related to deferred revenue, inventory fair value adjustment, amortization of intangible assets, stock-based compensation expense, interest expense and amortization of deferred issuance cost, and certain classification to conform to the Company's accounting policies.



	Twelve months ended December 31,
	2017		2016			2015
	(in thousands, except per share data)
Pro forma net revenues	$	716,723	$	719,799		$	523,241
Pro forma net income (loss)	$	20,770	$	(1,044	)	$	2,245
Pro forma net income (loss) per share	$	0.54	$	(0.03	)	$	0.06
Weighted average number of shares	38,712		36,156			36,699